Rekombinanter SLC45A3 Antikörper (N-Term)
Kurzübersicht für Rekombinanter SLC45A3 Antikörper (N-Term) (ABIN7879659)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Recombinant Prostein Antibody / SLC45A3 (azide and preservative free)
-
Aufreinigung
- Protein A affinity chromatography
-
Immunogen
- An N terminus region peptide from the human protein was used as the immunogen for the recombinant Prostein antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Prostein antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the recombinant Prostein antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
-
Andere Bezeichnung
- Prostein
-
Hintergrund
- Human prostein is a 553 aa protein identified by cDNA library subtraction and subsequent high throughput microarray screening of prostate cancer. Prostein has multiple transmembrane domains. Prostein has been shown to be uniquely expressed in normal and cancerous prostatic tissues. By immunohistochemistry, prostein is expressed in the vast majority of normal and malignant prostatic tissues, regardless of grade and metastatic status. No protein expression is detected in normal and malignant tissue samples representing the great majority of essential tissues and tumors. In particular, prostein is expressed in most of poorly differentiated prostatic carcinoma, including small cell prostate carcinoma. Prostein is more specific and sensitive for prostatic carcinomas than PSA and PSAP.
-
UniProt
- Q96JT2
Target
-